TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition (Homo sapiens)

From WikiPathways

Revision as of 05:09, 8 August 2019 by Khanspers (Talk | contribs)
Jump to: navigation, search
1Late Response TFEpithelial MarkersEMT Transcription FactorsMesenchymal MarkersSMAD PathwayE-CADSNAI1MAPKTNCCDH16VIMFN1N-CADERKRUNX2PI3KSMAD3ID1AKTSNAI2TGF-BSMAD2SMAD4CDH6PPPPPPPNon-SMAD PathwayEarly Response TF


Description

This pathway is based on the Figure 7 of "Cadherin 6 Is a New RUNX2 Target in TGF-β Signalling Pathway" (see bibliography). TGF-B is a target gene in thyroid cells in the causation of cancer. When TGF-B is activated, the pathway can take 2 directions, through a SMAD pathway or a Non-Smad pathway. Through the SMAD pathway, SMAD separates into SMAD2/3, SMAD4, and involves phosphates into the nuclear signalling. Through the Non-SMAD pathway, the activation of MAPK and Pi3k causes the activation of ERK, AKT and phosphates, and then into the nuclear signalling. Within the nuclear signalling, EMT-TF has two responses, early and late. With the early response, EMT-TF signals to Id1 and RUNX2, and with the late response, EMT-TF signals to Snai1 and Snai2. Depending on the response also dictates the type of marker that will follow. If early, N-CAD,FN1,VIM,TNC, and CDH6 all cause the activation of the Mesenchymal markers. If late, E-CAD, and CDH16 cause the inhibition of the Epithelial Markers. Proteins on this pathway have targeted assays available via the CPTAC Assay Portal

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

  1. Sancisi V, Gandolfi G, Ragazzi M, Nicoli D, Tamagnini I, Piana S, Ciarrocchi A; ''Cadherin 6 is a new RUNX2 target in TGF-β signalling pathway.''; PLoS One, 2013 PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
128360view21:32, 2 February 2024Ash iyerAdded protein complex oject and added pathway identifier for SMAD pathway
128349view06:46, 2 February 2024Khanspersspecified gene product node xrefs, layout, clarification
117840view15:13, 22 May 2021EweitzModified title
117837view15:11, 22 May 2021EweitzModified title
106478view19:42, 3 September 2019KhanspersModified description
105460view05:09, 8 August 2019KhanspersModified description
90120view00:17, 14 October 2016Khanspersupdated layout and interactions
89942view13:56, 6 October 2016EgonwModified description
88619view02:02, 12 August 2016AAR&CoAdded Data Nodes
88618view02:01, 12 August 2016AAR&CoPeriodical save, work in progress
87420view11:32, 22 July 2016MkutmonOntology Term : 'signaling pathway' added !
87310view21:17, 20 July 2016AAR&CoModified description
87306view20:51, 20 July 2016AAR&CoOntology Term : 'thyroid cancer' added !
87305view20:48, 20 July 2016AAR&CoNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
AKTGeneProductENSG00000142208 (Ensembl) AKT Not Specified
CDH16GeneProductENSG00000166589 (Ensembl)
CDH6GeneProductENSG00000113361 (Ensembl)
E-CADGeneProductP12830 (Uniprot-TrEMBL)
ERKGeneProductP27361 (Uniprot-TrEMBL) ERK Not Specified
FN1GeneProductENSG00000115414 (Ensembl)
ID1GeneProductENSG00000125968 (Ensembl)
MAPKGeneProductENSG00000100030 (Ensembl) MAPK Not Specified
N-CADProteinA0A024RC42 (Uniprot-TrEMBL)
PI3KGeneProductP91634 (Uniprot-TrEMBL)
RUNX2GeneProductENSG00000124813 (Ensembl)
SMAD2GeneProductENSG00000175387 (Ensembl)
SMAD3GeneProductENSG00000166949 (Ensembl)
SMAD4GeneProductENSG00000141646 (Ensembl)
SNAI1GeneProductENSG00000124216 (Ensembl)
SNAI2GeneProductENSG00000019549 (Ensembl)
TGF-BGeneProductP01137 (Uniprot-TrEMBL)
TNCGeneProductENSG00000041982 (Ensembl)
VIMGeneProductENSG00000026025 (Ensembl)

Annotated Interactions

No annotated interactions

Personal tools